GSK's Bepirovirsen Becomes First Approved Functional Cure for CHB
Global Biotech Funding Rebounds 103% YoY in Q2'26, Driving CXO Demand
BI Halts Phase I Trial of ADHD Asset After Safety Event
Genentech Licences Hanmi's CRHR2 Urocortin Analogue for Up to USD 2.3bn
Qilu's KRAS G12D Inhibitor Shows 78.6% DCR in NSCLC Phase I